PRODUCT LIABILITY FDA DEFENSE LANGUAGE CONSIDERATION EXPECTED TO BE POSTPONED IN SENATE UNTIL CONFEREES MEET; FLOOR DEBATE CONTINUES INTO WEEK TWO
Executive Summary
The Senate seems likely to defer consideration of an "FDA defense" amendment to product liability legislation until the conference committee meeting on the bill, although Sen. Kyl (R-Ariz.) has said he will offer an FDA defense amendment during the ongoing Senate floor debate.